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Abstract: Fluid and solute transporters of the retinal pigment epithelium (RPE) are core components
of the outer blood–retinal barrier. Characterizing these transporters and their role in retinal homeostasis may provide insights into ocular function and disease. Here, we describe RPE defects in tvrm77
mice, which exhibit hypopigmented patches in the central retina. Mapping and nucleotide sequencing of tvrm77 mice revealed a disrupted 5’ splice donor sequence in Slc4a5, a sodium bicarbonate
cotransporter gene. Slc4a5 expression was reduced 19.7-fold in tvrm77 RPE relative to controls, and
alternative splice variants were detected. SLC4A5 was localized to the Golgi apparatus of cultured
human RPE cells and in apical and basal membranes. Fundus imaging, optical coherence tomography,
microscopy, and electroretinography (ERG) of tvrm77 mice revealed retinal detachment, hypopigmented patches corresponding to neovascular lesions, and retinal folds. Detachment worsened and
outer nuclear layer thickness decreased with age. ERG a- and b-wave response amplitudes were
initially normal but declined in older mice. The direct current ERG fast oscillation and light peak were
reduced in amplitude at all ages, whereas other RPE-associated responses were unaffected. These
results link a new Slc4a5 mutation to subretinal fluid accumulation and altered light-evoked RPE
electrophysiological responses, suggesting that SLC4A5 functions at the outer blood–retinal barrier.
Keywords: sensitized chemical mutagenesis screen; mouse genetics; inherited retinal disease;
retinal dysplasia
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1. Introduction
The transport of nutrients, electrolytes, gases, water, and waste products between
the retina and the systemic circulation is regulated by the blood–retinal barrier (BRB) [1].
Disruption of the BRB affects retinal homeostasis and visual function [2] and is implicated
in major ocular diseases [3–5]. In most mammals, including humans and mice, the interface
between the retina and circulation consists of two components: the inner BRB, which
mediates transport between cells of the inner retina and the retinal vasculature, and the
outer BRB, which mediates transport between the photoreceptor outer segments and the
choroidal vascular bed (choriocapillaris). An essential component of the outer BRB is
the retinal pigment epithelium (RPE), an epithelial monolayer that lies between the outer
segments of the retina and the vascular endothelial cells of the choriocapillaris [1,6–8].
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A core function of the RPE is to regulate subretinal fluid composition, which depends
on the selective transport of ions and other solutes to and from this compartment, as
well as on the transport of water to the choriocapillaris [1,6–10]. Ion, solute, and water
transport are coordinated on short timescales to maintain an ionic environment suitable for
photoreceptor signaling and recovery following light stimuli and on longer timescales to
ensure a close apposition of outer segments with RPE apical processes, which is required
for photoreceptor homeostasis. Physiological and pharmacological studies of vertebrate
tissues and cultured cells have demonstrated that ATP-dependent transport of Na+ and
K+ at the apical RPE provides the primary energetic basis for ion and water transport.
Water transport is secondary to net ion efflux from the RPE, mainly of K+ and Cl− ; other
major solutes of the subretinal space that influence water efflux include H+ , CO2 , H2 CO3 ,
HCO3 − , and lactate. Further, a number of RPE proteins are known or postulated to mediate
solute and water transport, such as the apical Na+ , K+ ATPase, potassium channel KCNJ13
(Kir7.1), Na+ -K+ -2Cl− cotransporter, and Na+ -H+ antiporter; basolateral chloride channels
CFTR, BEST1, and CLCN2 (ClC-2) and the Cl− -HCO3 − exchanger SCL4A2 (AE2); apical
and basolateral AQP1 (aquaporin), monocarboxylate transporters MCT1 and MCT3, and
sodium bicarbonate cotransporters; and intracellular carbonic anhydrase, which converts
dissolved CO2 gas to H2 CO3 [1,6–10]. However, uncertainties remain about the contribution
of these specific transporters and channels to RPE ion, solute, and water transport in vivo,
which may benefit from studying animal models that disrupt them. For example, the
retinal degenerative phenotype of a Clcn2 knockout mouse was rescued by an RPE-specific
Clcn2 expression construct, demonstrating that CLCN2 function in the RPE is critical for
retinal homeostasis. Surprisingly, the expressed protein was localized to the apical RPE
in vivo, raising the possibility that it does not function as a basolateral transporter as widely
postulated [11].
In the present work, we characterize a mutant mouse line, tvrm77, identified by the
Translational Vision Research Models (TVRM) program at the Jackson Laboratory (JAX). In
this program, new mouse models of ocular disease are developed from C57BL/6J (B6) mice
and B6-derived mutant strains by chemical mutagenesis and phenotypic screening [12,13].
As last tabulated in 2016, 34 disease models have been identified through the TVRM
program and are currently available for distribution to the scientific community, while
additional heritable mutants, including tvrm77, remain to be characterized [14]. In an earlier
summary of the program, the tvrm77 phenotype was described as having central retinal
patches due to autosomal recessive inheritance of a mutation on chromosome (Chr) 6 [12].
Here, we show that the tvrm77 phenotype is associated with a mutation in Slc4a5, which
encodes an integral membrane solute carrier of the bicarbonate transporter family [15]. Slc4a5
is widely transcribed in mammalian tissues [16], and SLC4A5 (also known as NBC4 or
NBCe2) isoforms arising from alternative promotors and splicing are detected at the plasma
membrane of epithelial cells in the bile duct and liver [17], the kidney outer medullary
collecting duct [18], and the brain choroid plexus [19–23]. Physiological studies including
the analysis of Slc4a5 knockout mice established that SLC4A5 functions in these tissues
as an electrogenic sodium bicarbonate cotransporter [20,21,23–26]. Previous analysis of
ocular pathology in an Slc4a5 knockout strain revealed retinal detachment and a loss of
retinal function, which were attributed to the loss of photoreceptor and retinal ganglion
cells [21]. SLC4A5 mutations have not been linked to any monogenic human diseases,
although variants have been associated with an increased risk of elevated blood pressure
and an increased sensitivity of blood pressure to a high sodium intake [27–30].
Given that SLC4A5 transport functions have been documented in epithelial tissues [18–23]
and that retinal detachment in mice is associated with RPE dysfunction [31–33], we considered the hypothesis that a loss of SLC4A5 function in the RPE might contribute to the
reported retinal detachment and accompanying ocular phenotypes in Slc4a5 mutant mice.
Our studies support this hypothesis and advance our understanding of SLC4A5 function
at the outer BRB.
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Figure 1. Representative fundus phenotypes of tvrm77 mice and identification of the causative
mutation. (A) Bright-field fundus image of a female (F) B6 mouse at 1 month of age. (B–F) Fundus
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images of tvrm77 mice (male (M), 0.9; F, 2.1; M, 1.7; M, 5.0; and M, 11.5 months of age). Variable
phenotypes were noted, including hyperreflective white lines (yellow arrowheads), hypopigmented
patches (white arrowheads), and, in older mice (E,F), diffuse spots (white asterisks) and a white
haziness or halo toward the peripheral retina (yellow asterisks). Small bright spots were evident,
particularly in older tvrm77 eyes, throughout the region imaged (red arrowheads indicate a single
spot as an example). (G) DNA sequence of the splice donor exon 3–intron 3 junction of the mouse
Slc4a5 gene (RefSeq Select mRNA transcript NM_001166067.1 is used as the reference for exon and
intron numbering). DNA bases corresponding to the conserved mRNA 5’ splice donor sequence of
exon 3 are highlighted (red box), and the nucleotide affected in tvrm77 is highlighted in yellow. Slc4a5
DNA sequencing chromatograms of the parental strains (B6, C57BL/6J; D2, DBA/2J; C3, C3A.BLiAPde6b+ /J) and mice from the tvrm77 maintenance colony, as well as mapping crosses, are shown. The
number of mice sequenced with the observed phenotype is indicated. (H) Protein-coding transcripts
for mouse Slc4a5 on Chr 6 listed at the National Center for Biotechnology Information (Reference
GRCm39 C57BL/6J, NC_000072.7 (8316661183293218)). Transcripts include one RefSeq Select and
five variant transcripts (X1–X5; transcripts and corresponding accession sequences are labeled in
blue). Exons are numbered as in the RefSeq Select transcript, except that the first and upstream
exons in transcript variants are numbered 1a–1e to retain identical numbering for downstream exons
common to all transcripts. The locations of exon-specific sequencing primers for cDNA analysis are
indicated by inverted triangles with arrows indicating 50 –30 orientation. Coding exons, dark green;
non-coding exons, light green. (I) Alternatively spliced transcripts as assessed by cDNA analysis
of homozygous tvrm77 RPE. Normal (black lines) and alternative (red lines) Slc4a5 mRNA splicing
events are shown; exons are numbered as in (A). The mutation in intron 3 is indicated by an asterisk.
Transcripts using a cryptic splice site in intron 3 or skipping exon 3 entirely were observed. The
SLC4A5 polypeptide predicted from the RefSeq Select transcript in tvrm77 mice is indicated below
each splicing diagram. The first position corresponds to the initiating methionine; amino acids absent
from the wild-type sequence are indicated in red.

2.2. Analysis of RPE Slc4a5 mRNA Transcripts
The ocular phenotypes of tvrm77 mice suggested that the gene is expressed in the
posterior eye. Previous cell-specific transcriptome analysis of the mouse retina indicated
that Slc4a5 mRNA was enriched 3.4- to 3.9-fold on average in horizontal cells relative
to other retinal cell types [35,36]. This biased expression of the mRNA in horizontal
cells is consistent with the immunolocalization of SLC4A5 predominantly to the outer
plexiform layer [21], which contains horizontal cell processes. However, murine Slc4a5
and its mammalian orthologs are also expressed in epithelia of many tissues [17–23].
Notably, Slc4a5 mRNA has been detected in the mouse iris, ciliary bodies, and RPE at
levels that exceed retinal expression 15-, 35-, and 76-fold, respectively (BioGPS, GeneAtlas
MOE430, gcrma). Slc4a5 transcripts have also been detected in the RPE of C57BL/6NCrl
and C57BL/6J mice by bulk and single-cell RNA sequencing, respectively [37,38].
To assess the effects of the tvrm77 mutation on Slc4a5 expression in the RPE, mRNA
levels in RPE-enriched cell lysates were determined by qRT-PCR. Slc4a5 mRNA was detected in B6 samples and was decreased 19.7-fold in tvrm77 samples (p = 0.05, two-tailed
Student’s t-test; n = 4 and 3 for B6 and tvrm77, respectively).
Multiple promoters and alternative splicing events generating six transcripts are documented for the murine Slc4a5 gene (Figure 1H, RefSeq Select and variant transcripts
X1–X5). PCR products amplified from cDNA prepared from B6 and tvrm77 RPE RNA
samples were sequenced to determine the effect of the mutation on transcript processing.
The amplification of B6 RPE samples using primers mF and mR (see Data S1 for primer
sequences) yielded a product matching the known sequences of the RefSeq Select and
X4 transcripts, which are identical within the region amplified. The use of primers F03 and
mR identified products with a sequence corresponding to that of X1, indicating that transcripts expressed from an upstream promoter previously identified in rats [22] are also
present in the wild-type mouse RPE. By contrast, analysis of tvrm77 RPE with the mF and
mR primers revealed two novel splicing events. In one, the use of a cryptic splice site
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Figure 2. Expression of SLC4A5 in cultured human RPE differentiated from pluripotent stem cells.
(A,B) Double-label indirect immunofluorescence micrographs of staining for Golgi marker GORASP2
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(green) and SLC4A5 (red) on RPE differentiated (Day 30) from human embryonic stem cell line WA09
(A) or human iPSC line A04 (B) and grown on tissue culture plastic. Nuclei are counterstained with
DAPI (blue). Scale bar, 10 µm. (C) Higher power magnification of double-label staining of WA09 cells
as in (A,B). Scale bar, 10 µm. (D,E). Possible membrane distribution of SLC4A5, as determined by
deconvolution confocal microscopy, in WA09 cells grown on transwell membranes and stained with
anti-SLC4A5 antibody and DAPI. Single z-slices of the same image stack are shown adjacent to
the corresponding orthogonal projections (xz, yz). A falloff of faint blue cellular fluorescence was
used to approximate the apical cell boundary (corner brackets); the transwell membrane surface
defined the basal cell boundary. Bright SLC4A5 puncta (yellow arrowheads) near the apical (D) and
basal (E) boundaries were distinct from predominant staining in the central cell (asterisk) and may
therefore represent membrane-associated rather than Golgi-localized SLC4A5. (F) A single z-slice and
orthogonal projections of an image stack acquired from the same cells, which were treated identically
except for the omission of primary antibody. SLC4A5 signal was not observed. Scale bar in (F), 5 µm,
applies to (D–F).

2.4. Change in Lesion Prevalence with Age and Generation
Evidence that the Slc4a5 gene and protein are normally expressed in the RPE led us
to consider whether RPE morphology and function were altered in tvrm77 mice. We first
reviewed the prevalence of indirect ophthalmoscopy phenotypes with age to assess disease
onset and progression. White-line lesions in one or both eyes were observed in 65% of
tvrm77 mice (28/43 mice, including 24 F and 19 M mice) at 0.9–1.2 months of age, the earliest
ages examined. The prevalence of these lesions was similar at older ages: 72% (26/36 mice,
17 F and 19 M) at 1.7–3.7 months and 62% (18/29, 19 F and 10 M) at 4.1–11.5 months of age.
Thus, this phenotype is established early and remains stable (Figure S1). By contrast, the
prevalence of a peripheral halo or haziness increased from 14% (6/43) at 0.9–1.2 months
of age to 97% (35/36) and 100% (29/29) in the two older groups, respectively, indicating
progression of this phenotype with age (Figure S1). These results suggested that white-line
lesions could be characterized in young adult mice, whereas the peripheral halo phenotype
needs to be examined in older mice.
Indirect ophthalmoscopy also indicated that the white-line lesion phenotype decreased
in frequency with an additional backcross to B6 from N5 to N6 . At 0.9–1.2 months of age,
a statistically significant decrease in white-line lesion prevalence in one or both eyes was
observed among mice from the later generation (N5 : 93%; 14/15, 6 F and 9 M; N6 : 50%;
14/28, 18 F and 10 M; chi-square test, p = 4.4 × 10−3 ). This observation raises the possibility
that, although the phenotype appears to require the tvrm77 mutation, the pathogenesis
of the white-line lesion phenotype may be influenced by additional mutations in as-yetunidentified modifier genes.
2.5. Noninvasive Imaging of White-Line Lesions and Hypopigmented Patches
Noninvasive imaging was performed to characterize the posterior ocular defects. In
agreement with indirect ophthalmoscopy, fundus imaging of B6 (Figure 3A) and tvrm77
mice (Figure 3C,F,I) at 0.9–1.0 months of age confirmed the absence of white-line lesions
in control eyes (0%; 0/11 eyes from 4 F and 7 M mice) and their presence in tvrm77 eyes
(48%; 20/42 eyes, 12 F and 16 M mice). The association of lesions in fundus images
of one or both eyes (12/28) with the tvrm77 genotype was statistically significant (chisquare test, p = 9.1 × 10−3 ). Lesions ranged in number from one to five among fundus
images of 20 affected eyes of 6 F and 10 M mice and varied in length from small dots to
lines occupying more than a third of the diameter of the fundus image (Figure 3C,F,I).
Hypopigmented patches were absent in fundus images of B6 control mice (0/11, 4 F and
7 M mice) but present in 64% of images of tvrm77 eyes (27/42, 12 F and 16 M mice). The
association of hypopigmented patches in one or both eyes (19/28) with the tvrm77 genotype
was also statistically significant (chi-square test, p = 1.4 × 10−4 ). These lesions typically
feature a bright border surrounding darker islands (Figures 1C,D and 3C,I), typical of focal
RPE changes at neovascular lesions, as characterized by fundus imaging in other mouse
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OCT was also performed on the eyes of B6 and tvrm77 mice at 0.9–1.0 months of age,
including some of the same eyes assessed by bright-field fundus imaging (Figure 3). Eyes of
B6 mice exhibited a normal fundus appearance (Figure 3A) and normal retinal lamination
by OCT (Figure 3B, Video S1). Among affected tvrm77 mice, the shortest dot-like whiteline lesions (Figure 3C) appeared as a hyperreflective intrusion into the outer retina, with
minimal effect on total retinal thickness (Figure 3D, asterisk; Video S2). A thinned outer
nuclear layer was detected above the hyperreflective region, and the outer plexiform and
inner nuclear layers (OPL and INL, respectively) were distorted above it. A hyporeflective
gap was observed at the base of the lesion. Focal RPE thickening was observed near
hypopigmented patches, consistent with the OCT appearance of RPE alterations known to
accompany retinal neovascular structures [45–47]. In longer white-line lesions (Figure 3F,I),
a hyperreflective core was observed by OCT (Figure 3G,H,J,K, asterisks; Videos S3 and S4),
but the distortion of retinal layers and local increase in total retinal thickness was more
pronounced than that associated with dot-like lesions. Focal thickening of the RPE layer
was observed in the largest lesions (Figure 3H,J,K, arrowheads), often occurring in the same
region as the hypopigmented lesions detected by brightfield fundus imaging (compare
Figure 3I,K). In the largest lesions, a thinned ONL appeared both below and above the
hyperreflective core along much of its length (Figure 3G,H,J,K, asterisks; Videos S3 and S4),
although at some locations, the ONL was interrupted and the hyperreflective core extended
from the OPL toward the outer retina (Figure 3K).
We searched the literature for retinal lesions resembling the white-line lesions, particularly as characterized by OCT. Outer and full-thickness retinal folds that develop as
a complication of rhegmatogenous retinal detachment surgery [48] appear as pale linear
features by color fundus imaging and corresponding hyperreflective intrusions by OCT,
which distend the overlying retinal layers and cause a local increase in total retinal thickness [49–51]. Retinal folds with similar color fundus imaging and OCT features are also
found in inherited forms of canine retinal dysplasia [52]. Our phenotypic observations
suggest that the white-line lesions in tvrm77 mice are retinal folds.
2.6. Retinal Detachment and Layer Thinning
We hypothesized that the peripheral haziness or halo observed by indirect ophthalmoscopy in older tvrm77 mice corresponds to regions of retinal detachment, as documented
in fundus images obtained from retinal detachment models, such as homozygous Prkcqrpea1
mice [32]. Fundus images centered on the optic nerve of B6 mice did not indicate haziness
at 1, 2, or 4 months of age (Figures 3A and 4A,B) or in tvrm77 mice at 1 or 2 months of age
(Figures 3C and 4C). In B6 mice, the corresponding OCT volume datasets indicated a close
apposition of the retina with the RPE. By contrast, in tvrm77 mice at 4 months of age or
older, substantial haziness was apparent within the imaged region (Figure 4D). At this age,
OCT indicated disorganization of the outermost retinal layers and a variable hyporeflective
region between the retina and RPE, which was more pronounced toward the periphery
(Figure 4G,H, arrowheads; Videos S6 and S7). Hyporeflective regions were apparent even
at 1 and 2 months of age (Figures 3G,H and 4D,E, arrowheads; Videos S2–S4). In OCT
scans of human patients and animal models, hyporeflective areas between the retina and
RPE indicate subretinal fluid, associated with pathological [53,54], post-surgical [55], or
experimentally induced retinal detachment [56].
To examine the progression of the retinal detachment phenotype, retinal layer thicknesses in OCT volume datasets were measured as a function of age. The distance between
the external limiting membrane (ELM) and the scleral surface of the RPE, which we denote
as the ELM–Bruch’s membrane distance (ELM-BM), showed a statistically significant increase in tvrm77 compared to B6 control mice at all ages examined (Figure 4I, two-tailed
Student’s t-test; p = 1.8 × 10−3 ; p = 1.5 × 10−6 ; and p = 1.9 × 10−4 at 1, 2, and 4 months of
age, respectively; B6, n = 5–9; tvrm77, n = 5–8). These results suggest that retinal detachment
initiates during early development in tvrm77 mice.
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hyporeflective regions (arrowheads) both below white-line lesions (asterisk) and in regions where
lesions are not apparent. The full OCT volume dataset is presented in Video S7. Fundus images
were aligned to the corresponding OCT datasets using Fiji. The vertical scale of the OCT images was
increased two-fold to enhance image detail. (I) ELM-BM distance as a function of age as measured
by OCT in B6 and tvrm77 eyes. (J) Western analysis for ezrin transfer assay. Lysates of total eyecup
or peeled retina were analyzed by Western blotting using antibody against ezrin. Blot images are
pseudocolored to indicate Ponceau S protein (red) and ezrin fluorescence (grayscale). The position
of a 75 kDa molecular weight protein standard is indicated. (K) Quantitation of the relative ezrin
levels in eyecup and peeled retina from the Western blot shown in (J). Relative ezrin values were
normalized by dividing by the mean B6 value. Full-length blots are provided in Figure S2. (L) ONL
thickness as a function of age as measured by OCT in B6 and tvrm77 eyes. In (I,K,L), bars indicate
mean (±SD), and statistical significance is indicated by asterisks: * p < 0.01; ** p < 0.001; *** p < 0.00001.
Scale bar in (B) applies to (D,E,G,H).

To provide additional evidence for retinal detachment, we used a retina–RPE adhesion
assay that examines the transfer of ezrin from the RPE apical surface to the retina, which is
measured by Western analysis after the retina is peeled from the RPE [32,57]. A statistically
significant decrease in the relative amount of ezrin detected in peeled retinas was observed
in tvrm77 compared to B6 eyes (Figure 4J,K; two-tailed Student’s t-test, p = 0.023, n = 3 for
both strains). The total amount of ezrin in tvrm77 and B6 eyecups was similar, suggesting
that ezrin accumulation was unaffected by the mutation. These results indicate a decreased
association of the retina and RPE consistent with retinal detachment.
Retinal detachment is often associated with progressive degeneration of the photoreceptor layer [58]. To test for potential degeneration, we measured the ONL thickness
by OCT at 1, 2, and 4 months of age (Figure 4L). ONL thickness showed a statistically
significant decrease in tvrm77 mice compared to B6 mice at 4 months of age (two-tailed
Student’s t-test, p = 1.2 × 10−5 ; B6, n = 8; tvrm77, n = 7). Thus, the tvrm77 mutation is also
associated with retinal degeneration characterized by a loss of photoreceptor cells.
2.7. Histological Characterization of Retinal Folds and Neovascular Lesions
To characterize the tvrm77 disease phenotype at the tissue and cellular level, mutant
and B6 mice were examined at 2 months of age by histology. Retinal layers were wellordered in the posterior eyes of B6 samples (Figure 5A,B). By contrast, the posterior eyes
of tvrm77 mice, which were documented by indirect ophthalmoscopy or fundus imaging
to contain white-line lesions, included one or more prominent retinal lesions with altered
lamination (Figure 5C,D, asterisks). Additionally, ectopic nuclei were noted in the subretinal
space of tvrm77 mice, which may correspond to immune cells mobilized to the retina–RPE
interface, as observed in other models of retinal dystrophy [59–62].
Analysis of serial sections supported the features of white-line lesions as identified
by OCT. At the start of the lesion, a small infolding of the ONL was observed above a
perturbed RPE region, which included ectopic subretinal nuclei (Figure 5E–G). A more
detailed view indicated a focal doubling of the RPE layer and voids in the subretinal space,
which may correspond to excess subretinal fluid at this location (Figure 5F0 ). In a nearby
section, an apparent neovascular structure was observed adjacent to a prominent outer
retinal fold (Figure 5H,H0 ). Progressive distortion of the OPL and INL and a focal increase
in total retinal thickness were observed as the folds became more pronounced. Subsequent
sections exhibited a pseudorosette structure consisting of a thinned layer of photoreceptor
nuclei surrounding an eosinophilic region (Figure 5I–L), which was contiguous with the
eosinophilic inner and outer segments of photoreceptor cells observed in folds nearer to
the lesion start (Figure 5H). The interior of the pseudorosettes included nucleated cells,
which may be immune-related, and voids that may correspond to accumulated subretinal
fluid. The presence of the pseudorosette structure in 16 consecutive sections suggests that
it corresponds to the hyperreflective core and hyporeflective surrounding of white-line
lesions observed by OCT. An additional neovascular structure was observed near the end
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2.8. Fluorescence and Electron Microscopy of Retinal Folds, Detachment, and Neovascularization
To detect additional features of tvrm77 lesions, we examined fixed ocular tissues by fluorescence and transmission electron microscopy (TEM). Immunofluorescence microscopy
of control B6 mice using antibodies against rhodopsin (RHO) revealed photoreceptor outer
segments contacting the RPE (Figure 6A, green). Antibodies against tight-junction protein 1
(TJP1) revealed an intact ELM at the outer ONL boundary (Figure 6A, red). An identical
arrangement was observed in unaffected regions of tvrm77 eyes (Figure 6B). However,
at tvrm77 lesions, RHO staining was limited to the pseudorosette interior, and an intact
TJP1 band encircling the interior was observed at the ONL boundary. The preservation
of outer segments and ELM suggests that the lesions are created by the infolding of a
developmentally intact retina. TEM of B6 eyecups indicated a normal apposition of photoreceptor outer segment with the RPE, which was disrupted in tvrm77 mice by subretinal
fluid and debris (Figure 6C,D). Occasional immune cells were observed at the retina–RPE
interface, supporting the histological observations (Figure 6E). Flatmounts of B6 retinas
stained with isolectin B4 to visualize blood vessels revealed three vascular layers with
no evidence of abnormal vascular structures (Figure 6F,H). By contrast, tvrm77 retinas
exhibited neovascular structures departing from the deep vascular bed and extending
toward the outer retina (Figure 6G,I–O). These results provide further evidence that retinal
Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW
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neovascular structures form in tvrm77 mice.
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2.9. Aberrant ERG Response

To assess functional changes, ERGs were examined at multiple ages. Strobe flash
ERGs were used to examine the response properties of the outer neural retina. At 2 months
of age, ERGs of B6 and tvrm77 mice were comparable under dark-adapted conditions
(Figure 7A,B,D). These results indicate that the function of rod and cone photoreceptors as
well as of bipolar cells, which generate the major components of the strobe flash ERG, is
maintained in tvrm77 animals. At 12 months of age, ERGs of tvrm77 mice were significantly
reduced (Figure 7C). This reflects an age-dependent decline in response amplitude that
began after 6 months of age (Figure 7D). RPE function was examined using dc-ERG
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retinal folds. Our findings suggest a role for SLC4A5 relevant to the function of the outer
retinal BRB, perhaps through its function in electrolyte and fluid transport across the RPE.
3.1. RPE Expression of Slc4a5 and Its Disruption in tvrm77 Mice
Previous studies of three Slc4a5 mouse knockout models indicated functional expression of the gene and SLC4A5 protein in epithelial cells that regulate sodium bicarbonate
transport at important interfaces between the circulation and tissue compartments, including the blood–CNS barrier of the choroid plexus [21,23] and the collecting ducts and tubules
of the kidney [26,64,65]. Previous analysis of ocular pathology in one of the knockout strains
revealed retinal detachment, retinal ganglion cell and photoreceptor cell loss, outer segment
shortening and dysmorphology, and decreased ERG response amplitudes [21]. Immunohistochemistry with a non-commercial SLC4A5 antibody revealed prominent staining in the
OPL, which was absent in the knockout strain. These findings led the authors to suggest
that SLC4A5 might be important for pH buffering at the photoreceptor synaptic terminus,
possibly in a light-dependent fashion. A potential contribution of the RPE to the ocular
phenotypes was not discussed.
We describe a new Slc4a5 allele in tvrm77 mice that disrupts Slc4a5 splicing and
causes a 19.7-fold decrease in Slc4a5 mRNA levels. Multiple alternate transcripts were
confirmed in B6 control mice, consistent with transcription from two promoters, and were
altered similarly in the tvrm77 model. The tvrm77 transcripts were predicted to encode
SLC4A5 polypeptides that were prematurely truncated near the amino terminus and lacked
the transmembrane domain required for transport function. Thus, the Slc4a5tvrm77 allele
is likely to be a null allele, at least in the eye. Database and literature reports identify
Slc4a5 mRNA in the RPE, and our immunohistochemistry results confirmed that SLC4A5 is
produced by cultured human RPE cells. Based on these results and the evidence for
SLC4A5 presence and function in epithelial cells, we suggest that the ocular phenotypes
observed in tvrm77 mice, as well as in the knockout strain studied previously [21], are
attributable at least in part to a loss of SLC4A5 in the RPE.
3.2. Early RPE-Specific ERG Defects
Our ERG studies identified abnormalities in two ERG components generated by the
RPE, the FO and LP. Both components are generated by the basal RPE membrane. The
major factor underlying the FO is a hyperpolarization of the basal membrane of the RPE in
response to the initial decline in subretinal [K+ ] [65,66]. The LP reflects a depolarization
of the basal membrane of the RPE [67]. Although the specific ion channel that underlies
this ERG component has not been determined, it is interesting to note that heterozygous
Clcn2nmf240 mice expressing a single functional allele have a selective reduction of LP
amplitude [68]. In tvrm77 mice, only the FO and LP were reduced in amplitude. This
suggests that the primary impact of losing SLC4A5 function is on the basal membrane
where these components are generated. In comparison, the c-wave and off-response
components remained normal or were actually larger in amplitude in tvrm77 as compared
to B6 mice. This amplitude increase could reflect how the underlying components interact to
define the final waveform. In support of this idea, larger amplitude c-waves were obtained
from mice expressing only a single allele of Kir4.1 compared to B6 animals, reflecting the
contribution of Kir4.1 conductance to the negative-polarity slow PIII component, which
combines with the positive-polarity component generated by the apical RPE membrane to
define the c-wave [69].
3.3. Role of RPE SLC4A5 in Fluid Transport across the Outer BRB
Physiological studies of frog, bovine, human, and cultured human RPE have identified a system of integral membrane transporters and intracellular enzymes responsible for net movement of HCO3 − and H2 O from the subretinal space to the choroidal
circulation [7–9,70,71]. This system is postulated to remove excess CO2 and H2 O generated
by the high metabolic activity of photoreceptor cells, maintaining a negative hydrostatic
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pressure that ensures tight adhesion of the retina to the RPE apical surface. The functional importance of an electrogenic basolateral sodium bicarbonate cotransporter to this
system was established by physiological studies [70] and further supported by mathematical modeling [9]. SLC4A4 (NBC1) and SLC4A5 were considered as candidates for this
transporter based on high levels of the corresponding transcripts in native and cultured
human RPE [70,72]. SLC4A5 was the preferred candidate based on a comparison of HCO3 −
transport mechanisms in the RPE and choroid plexus epithelium (CPE), which is developmentally related to the RPE [73,74]. The Na+ :HCO3 − 1:3 stoichiometry of SLC4A5-mediated
efflux in the CPE [20] matched the inferred efflux stoichiometry of the unidentified electrogenic sodium bicarbonate transporter in the basolateral RPE [70]. Furthermore, the CPE
transports sodium bicarbonate and fluid from the circulation to the cerebrospinal fluid,
while the RPE moves these substances in the opposite direction, from the subretinal space
to the circulation. Thus, the localization of sodium bicarbonate transporters SLC4A4 and
SLC4A8 in the CPE basolateral membrane [73,74] and SLC4A5 in the apical membrane [20]
is expected to be reversed in the RPE [70]. SLC4A4 is found at the apical membrane of RPE
cells [75], reinforcing this prediction. A reversed apicobasal distribution of SLC4A5 and
other sodium bicarbonate transporters in the RPE is not unexpected, because the distribution of other RPE membrane transporters, such as the monocarboxylate transporter
SLC16A1, the Na+ ,K+ -ATPase, and the cystic fibrosis transmembrane conductance regulator, is opposite to their distribution in the CPE and other epithelia [71]. Thus, existing
evidence predicts that SLC4A5 is an electrogenic sodium bicarbonate transporter in the
basolateral membrane of the RPE.
In support of this prediction, we detected SLC4A5 in human iPSC-derived RPE cells.
However, most of the protein was localized to the Golgi apparatus, as reported in renal
proximal tubule cells [76]. Thus, we cannot exclude the possibility that SLC4A5 functions
predominantly in the Golgi apparatus, possibly controlling the cellular trafficking and/or
localization of other solute carriers that determine RPE electrolyte and fluid transport.
Nevertheless, SLC4A5 was also detected in puncta at the basolateral membrane, and our
ERG findings indicated a transport defect at the basolateral membrane in tvrm77 mice. In
addition, we found evidence for subretinal fluid accumulation based on the hyporeflective
OCT band in the subretinal space of tvrm77 mice at about 1 month of age that became more
pronounced in older animals, indicating a disruption of fluid transport from the subretinal
space. Together with the earlier physiological studies of RPE transport, these findings
raise the possibility that basolateral SLC4A5 regulates sodium bicarbonate and water efflux
across the RPE and outer BRB. Future studies to compare the electrolyte and fluid transport
properties of B6 and tvrm77 RPE may test this hypothesis directly.
3.4. A Possible Model of Exudative Retinal Detachment and Neovascularization Type 3
As the goal of the TVRM program is to provide mouse models of human ocular
disease [12–14], we searched the clinical literature for reports of disease phenotypes resembling those of tvrm77 mice. Retinal detachments are classified as exudative (serous),
due to subretinal fluid accumulation; rhegmatogenous, due to retinal breaks that allow the
vitreous to infiltrate below the retina; and tractional, due to the contraction of scar tissue on
the vitreal surface of the retina [77]. Our OCT and histological analysis did not indicate
retinal breaks or scar tissue on the vitreal surface of the retina, suggesting that tvrm77 mice
model exudative retinal detachment.
Retinal neovascular lesions have been reported in several ocular conditions. Idiopathic retinal telangiectasia with exudation [78], a spectrum of unilateral, sporadic disease
phenotypes that includes forms of Coats disease, is characterized by capillary networks,
which emanate from the deep retinal plexus, and exudative retinal detachment. A form of
age-related macular degeneration, macular neovascularization Type 3 (MNV3), also called
retinal angiomatous proliferation (RAP), consists of neovessels that originate from the deep
retinal plexus and in late stages anastomose with the choroidal circulation [79,80]. Macular
telangiectasia type 2 [81] is a bilateral neovascular disease presenting simultaneously with

Int. J. Mol. Sci. 2022, 23, 2220

17 of 26

local retinal detachment in the form of subfoveal fluid accumulation in 1–2% of affected
patients [82,83]. These diseases are associated with photoreceptor loss [78–81]. Thus, tvrm77
mice may recapitulate aspects of retinal neovascularization and degeneration as observed
in these diseases.
3.5. A Possible Model to Study Retinal Fold Formation
Although retinal folds in humans are not known to have genetic associations,
several types of folds have been observed in rhegmatogenous retinal detachment
(RDD) [84] and, more frequently, as a postoperative complication of surgery to correct this
condition [49,51,84–88]. Hydration folds, as detected by OCT prior to surgery, feature a
corrugated appearance of the outer retina, which is typically completely detached from the
underlying RPE [51,84]. By contrast, postoperative outer retinal folds are less frequent and
appear as hyperreflective retinal intrusions between the RPE and outer plexiform layers.
These lesions are observed in reattached retinas, although they are often accompanied by
local detachment at the site of the fold. Full-thickness folds compromise the entire retina
and may include a central hyperreflective intrusion. Like outer retinal folds, full-thickness
folds are also accompanied by local detachment. Hydration, outer retinal, and full-thickness
folds have been proposed to arise from an excess of subretinal fluid, which temporarily
overwhelms the fluid extrusion capabilities of the RPE. With time, outer retinal folds are
typically resolved without further intervention, presumably due to effective fluid extrusion
by the RPE. The clinical appearance of outer retinal and full-thickness folds by fundus
imaging and OCT is similar to that of white-line lesions observed in tvrm77 mice. By
analogy to outer retinal and full-thickness folds in humans, the lesions in tvrm77 mice may
fail to resolve due to a genetic defect in fluid extrusion from the subretinal space. Further
studies of tvrm77 mice may reveal whether these lesions are a consequence of exudative
retinal detachment caused by the Slc4a5 mutation or an independent phenomenon and may
yield insights into the post-surgery management of outer retinal and full-thickness folds.
The occurrence of retinal folds in dogs, also called canine retinal dysplasia, has been
observed in non-syndromic (sporadic) multifocal retinal dysplasia and in syndromic multifocal retinal dysplasia among Labrador retrievers and Samoyeds harboring the drd1
and drd2 (dwarfism with retinal dysplasia 1 and 2) mutant alleles [52]. Strikingly, retinal
detachment accompanies retinal folds in severe cases of the syndromic disease [52], as
in tvrm77 mice. The cross-sectional appearance of lesions observed in affected dogs by
OCT included hyperreflective cores in the outer retina that distort the overlying inner
nuclear layer and cause a local retinal bulge, identical to the white-line lesions observed in
tvrm77 mice. Retinal folds in affected drd1 and drd2 dogs are found near superior venules
and arterioles at the posterior pole, suggesting a possible retinal vascular contribution
to fold formation. Although the drd1 and drd2 loci harbor mutations in the COL9A3 and
COL9A2 genes, respectively [89], these mutations did not segregate with retinal folds, so
the causative gene or genes for this phenotype remain to be identified. It would be of
interest to examine whether canine SLC4A5 or other known regulators of RPE fluid flow
are altered in drd1 and drd2 canines exhibiting retinal dysplasia.
A previous study of Slc4a5 knockout mice, in which ocular phenotypes were characterized, did not report neovascular lesions or retinal folds [21]. The study included
OCT and microscopy of fixed ocular sections, which might have detected folds if they had
occurred within the region analyzed. However, in the absence of a technique to survey
the entire posterior eye, such as indirect ophthalmoscopy, it is possible that such lesions
occurred but were not detected in the knockout strain. Alternatively, differences in the
Slc4a5 allele (splice mutation versus gene trap) or in strain genetic background may have
resulted in an altered phenotype. In the previous study, the mutation was engineered
in 129S5/SvEvBrd embryonic stem cells, which were implanted into B6 blastocysts and
subsequently maintained in this strain. The mixed genetic background of the resulting
Slc4a5 knockout mice may have resulted in a decreased prevalence of neovascular lesions
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and retinal folds. Ocular phenotypes for two other Slc4a5 knockout strains [23,26] have not
yet been reported.
3.6. Study Limitations and Recommendations for Future Work
There are several limitations to this study. We were unable to detect mouse SLC4A5 in
native tissue using commercially available antibodies and therefore studied polarized
human iPSC-derived RPE cells in transwell culture. Antibodies that detect SLC4A5 in the
native mouse RPE are needed to determine basolateral localization in vivo. Our studies did
not address the possible contribution of Slc4a5 expression in other retinal cell types to tvrm77
phenotypes. For example, the expression of Slc4a5 mRNA has been documented in horizontal cells [35], and these cells have been implicated in retinal vascular development [90].
Cell-specific Slc4a5 ablation [91] may distinguish whether a loss of SLC4A5 function in
these cells or the RPE is sufficient to cause retinal detachment, folds, neovascularization,
and degeneration. Although we have backcrossed tvrm77 with B6 mice for six generations,
we cannot exclude the possibility that linked ENU-induced mutations in additional genes
may influence the observed phenotypes. Further backcrossing may reduce this possibility.
Finally, our studies do not resolve disease progression sufficiently to establish the order of
pathological events that cause the observed phenotypes. Longitudinal microscopy studies that include early postnatal time points may provide clues to the cause of subretinal
fluid accumulation and reveal the relationship between retinal neovascularization and the
formation of retinal folds.
3.7. Summary
Our studies of a new Slc4a5 mutant allele, tvrm77, in mice support a role for the
SLC4A5 protein in RPE cells at the outer BRB. The mutant mice may serve as a model of
exudative retinal detachment, retinal neovascularization, and retinal dysplasia. Although
we focused exclusively on the ocular phenotype, we note that previously reported Slc4a5
mutant strains exhibited abnormalities in the epithelia of the bile duct, liver, brain, and
kidney [17–23]. Thus, the tvrm77 mouse may be of value in defining the role of SLC4A5 in
the eye and also in these other organs.
4. Materials and Methods
4.1. Mice, Mutagenesis and Mapping
C57BL/6J (B6; JAX stock #000664) mice were obtained from the production colony at
JAX (Bar Harbor, ME, USA), mutagenized with ENU, and screened for ocular defects by the
TVRM program, yielding the tvrm77 line as described [12,13]. The line was initially maintained by backcrossing to B6 for five generations (N5 ) with intercrossing at each generation
to identify affected mice; once the mutation was identified, an additional backcross was
conducted, and N6 mice were maintained by intercrossing. The full designation for this
model is C57BL/6J- Slc4a5tvrm77 /Pjn; for simplicity, we retain the original strain designation
tvrm77, and unless otherwise indicated, the genotype is homozygous for the mutant allele.
Mice were housed in the Research Animal Facility at JAX on a 12 h light/12 h dark cycle
and provided an NIH31 (6% fat) diet and acidified water ad libitum. All animal procedures
were approved by the Institutional Animal Care and Use Committees of the JAX or Cleveland Clinic and adhered to the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research.
To map the chromosomal location of the tvrm77 mutation, affected females (presumed
homozygotes) were mated to male DBA/2J (D2; JAX stock #000671) mice to generate
F1 progeny which were subsequently intercrossed. F2 progeny were assessed by indirect
ophthalmoscopy at 8–10 weeks of age, and DNA was isolated from tail snips using a
modified NaOH lysis protocol [92]. For the genome scan, DNA pools of 10 affected and
10 unaffected mice were genotyped using a panel of 99 simple sequence length polymorphic
markers (SSLP) [93] that span the genome (The Jackson Laboratory Fine Mapping Facility,
Bar Harbor, ME, USA). The disease gene was localized to a 30 Mb region on mouse Chr 6

Int. J. Mol. Sci. 2022, 23, 2220

19 of 26

between SSLP markers D16Mit16 and D6Mit104. To further refine the critical region, a
second mapping cross was generated by intercrossing F1 progeny from an outcross of
homozygous B6-tvrm77 to C3A.BLiA-Pde6b+ /J (JAX stock #001912, also known as “sighted
C3H”). In total, 751 F2 DNAs (375 from B6 × D2 and 376 from B6 × C3A.BLiA-Pde6b+ /J
intercrosses) were tested for recombination with D6Mit188 and D6Mit9, markers flanking
the critical region (Chr 6:75447583–87426034 bp). The affected status of critical recombinants
was confirmed by progeny tests.
4.2. Mutation Analysis
To determine the causative gene mutated in tvrm77, total RNA was prepared from
whole eyes of tvrm77 and B6 control mice using TRIzol reagent (Life Technologies, Carlsbad,
CA, USA) according to the manufacturer’s instructions, and cDNA was generated with a
Retroscript reverse transcription kit (Ambion, Inc., Austin, TX, USA). The coding region
of the candidate gene Slc4a5 was amplified from cDNA using PCR, and purified products were sequenced. Subsequently, DNA from affected and unaffected F2 progeny and
parental strains including B6, D2, and C3A.BLiA-Pde6b+ /J was sequenced and compared
to determine the genomic position of the tvrm77 mutation in Slc4a5.
4.3. Analysis of Slc4a5 RPE Transcripts
RPE was isolated from 1-month-old tvrm77 mutant (n = 3) and B6J control (n = 4)
eyes as described [94]. Briefly, eyes were enucleated immediately from euthanized mice
and placed into phosphate-buffered saline (PBS). Angled Vannas scissors were used to
remove the anterior segment and lens just below the limbus. The retina was carefully
removed, exposing the RPE. Each eyecup was incubated for 10 min in RNAprotect Cell
Reagent (Qiagen, Hilden, Germany), with gentle agitation every few minutes. The posterior
eyecup was removed, and the RPE cell suspension was centrifuged at 3000× g for 5 min.
Supernatant was removed, and the cell pellet was flash frozen in liquid nitrogen and stored
at −80 ◦ C. RNA was extracted from the cell pellet using RNeasy Micro Kit (Qiagen, Hilden,
Germany) following manufacturer’s recommendations. cDNA was generated using 350 ng
total extracted RNA using RETROscript Reverse Transcription (Ambion, Inc., Austin, TX,
USA) according to manufacturer’s recommendations.
For qPCR, reactions were run in duplicate on an iCycler (Bio-Rad, Hercules, CA, USA)
at 95 ◦ C for 30 s, followed by 40 cycles of 95 ◦ C for 4 s and 60 ◦ C for 20 s using iTaq Universal
SYBR Green Supermix (Bio-Rad, Hercules, CA, USA). Each reaction contained 10 ng cDNA,
200 nM of each primer, and 10 µL iTaq Universal SYBR Green Supermix in 20 µL total
volume. The fold changes in expression were calculated using 2−∆∆Ct using Actb as a reference gene. Primer sequences for Slc4a5 include RT-F, GACCAGCCATTCATTGCATTT and
RT-R, CTCTCCCGGAAGGTCCTAATA; those for Actb include F1, CCAGTTCGCCATGGATGACGATAT and R1, GTCAGGATACCTCTCTTGCTCTG.
To determine the effects of Slc4a5 mutation on mRNA splicing, RPE cDNA was amplified using primers specific for Slc4a5 exons: mF, CCCCTTTCTTTCTCATTTGC; mR,
TTTTCCGCTGGTCTGTGTT; and F03, TTTGGAGCCTGGTGTCCAC. For samples amplified using the F03 primer, a second primer, bF CCTGAAACCAGGCAAGCCTC, was used
in a subsequent amplification step by nested PCR.
4.4. Human Pluripotent Stem Cell Culture
WA09 hESC (WiCell) and A04 hiPSC, a clonal derivative of HPSI0114i-kolf_2 [95],
were provided by Dr. Bill Skarnes, JAX. Cells were maintained in StemFlex defined culture
medium (Thermo Fisher Scientific, Waltham, MA, USA) as adherent cultures on a substrate
of a recombinant fragment of human vitronectin (Synthemax, Corning, Corning, NY, USA).
Cells were routinely passaged with a non-enzymatic dissociation reagent (ReLeSR, Stem
Cell Technologies, Vancouver, CB, Canada). Cells were used within 15 passages from
diploid master stocks, and undifferentiated cultures expressed cell surface markers and
transcription factors characteristic of the pluripotent state. Bimonthly testing confirmed the
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absence of contamination by mycoplasma or other adventitious microbial agents. Human
embryonic stem cell research was approved by the University of Connecticut Stem Cell
Research Oversight Committee on behalf of JAX.
4.5. Human RPE Cell Differentiation and SLC4A5 Expression
hESC or hiPSC differentiation into RPE followed the multistage protocol (differentiation, enrichment, and maturation phases) as described [40,41]. Undifferentiated hESC or
hiPSC grown in defined medium (see above) were transferred to Matrigel-coated plates
and incubated in basal medium (DMEM:F12 with N2B27 and non-essential amino acids)
supplemented with the following factors in this sequence: nicotinamide, noggin, DKK-1,
and IGF1 from Day 0–2; addition of FGF2 to the Day 0–2 combination from Day 2–4; Activin
A, DKK-1, and IGF-1 from Day 4–6; Activin A and SU5402 from Day 6–8; Activin A, SU5402,
and CHIR99021 from Day 8–14. Following induction of differentiation, cells were harvested
and transferred to X-VIVO-15 medium on Matrigel-treated plates from Day 14–42 and
then harvested and cultured in the same medium and substrate on tissue culture flasks,
slides, or transwell inserts. Cells were fixed or harvested for immunoblot analysis between
Day 30 and Day 120. Differentiation to RPE was confirmed by immunostaining with
antibodies to PEDF, ZO1, TIMP3, BEST1, RPE65, and transmission electron microscopy to
demonstrate melanosome granules.
Cultures on multiwell slides or transwell inserts were fixed for 30 min in 4.0%
paraformaldehyde in phosphate-buffered saline at 4 ◦ C. Antibodies used for immunostaining were rabbit anti-human SLC4A5 polyclonal (HPA036621; Sigma, St. Louis, MO, USA),
mouse anti-GORASP2 (CL2610; Abcam, Cambridge, UK), and mouse anti-BEST1 (E6-6;
Abcam). Secondary antibodies were Alexa488 goat anti-mouse Ig or Alexa594 goat antirabbit (both from Thermo Fisher Scientific, Waltham, MA, USA). Nuclei were counterstained with 40 ,6-diamidino-2-phenylindole. Stained preparations were examined using
either a Leica DMi8 inverted microscope (Leica, Wetzlar, Germany) equipped with epifluorescence illumination or a LSM800 confocal microscope (Carl Zeiss, Oberkochen, Germany).
Images were processed using the respective manufacturer’s software.
4.6. Live Imaging of Mouse Eyes
Noninvasive fundus imaging with a Micron III or IV retinal camera (Phoenix Research
Laboratories, Pleasanton, CA, USA) and a spectral domain OCT Envisu R2210 imaging
system (Leica, Wetzlar, Germany) were performed as described [96]. Briefly, Micron camera
videos of 100 frames were registered, averaged, digitally sharpened, and adjusted for
brightness and contrast in Fiji/ImageJ with a custom macro (available through JAX Eye
at the ImageJ update site). OCT image volumes were registered and averaged from 5 or
10 replicate rectangular scans (1000 × 100 × 1). Fundus images were rotated in Fiji/ImageJ
to match en face OCT stacks based on retinal vascular landmarks. OCT layer thicknesses
were determined from a B-scan selected from the OCT volume and centered on the optic
nerve head. Segmented lines roughly 200 µm in length were drawn along the ELM on
both sides of the optic nerve head roughly 400 µm from its center, fit to a spline curve,
interpolated (20 pixels), and straightened. A full-width vertical line was centered along the
straightened images, and the Plot Profile tool was applied to generate a plot of grayscale
intensity versus axial position. Plot coordinates were imported into a custom Excel template
that determined the distance between layers as measured at the midpoints between the
peak and valley of grayscale intensity, which define the boundaries of each retinal layer.
Values from each side of the optic nerve head were averaged.
4.7. Mouse Histology and Immunohistochemistry
Mice were sacrificed by CO2 asphyxiation. Enucleated eyes were placed in methanol:acetic
acid:PBS (3:1:4) and fixed overnight at 4 ◦ C. The following day, tissues were dehydrated
in an alcohol series and embedded in paraffin. Tissues were cut into 5 µM sections and
mounted on Colorfrost plus (Thermo Fisher Scientific) glass slides. For histological analysis,
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sections were stained with hematoxylin and eosin and visualized by light microscopy. For
immunohistochemistry (IHC), retinal sections were de-paraffinized and blocked in 1×
PBS, 0.5% Triton, and 2% normal donkey serum for 30 min at room temperature. Tissues
were then incubated in mouse anti-rhodopsin (MilliporeSigma, Burlington, MA, USA;
MA5-11741) and rabbit anti-TJP1 (Thermo Fisher Scientific, Waltham, MA, USA; 61–7300)
antibodies overnight at 4 ◦ C. After several washes in 1× PBS, sections were incubated
with a Cy3-conjugated (Jackson Immunoresearch, West Grove, PA, USA) rabbit and Alexa
Fluor 488-conjugated (Life Technologies, Carlsbad, CA, USA) mouse anti-IgG secondary
antibody (1:200) and stained with DAPI (Invitrogen, Waltham, MA, USA; D1306) to detect
nuclei. Localization of rhodopsin and ezrin were visualized by fluorescent microscopy
(DMLB, Leica), and images were acquired with QCapture software (QImaging, Surrey,
BC, Canada).
4.8. Transmission Electron Microscopy
Enucleated eyes from tvrm77 and C57BL/6J mice at 1 month of age were immersed
in 2.5% w/v glutaraldehyde, 2% w/v paraformaldehyde solution, 0.1 M sodium phosphate,
pH 7.2. The anterior segment was immediately removed, and the remaining posterior
segment was incubated in fixative for 3–4 h at room temperature followed by storage in
10-fold-diluted fixative for at least 12 h at 4 ◦ C. Eyecups were then transferred to 0.1 M
phosphate buffer and cut into transverse blocks (1 × 2 mm2 ). Tissue specimens were
post-fixed in 1% w/v osmium tetroxide, dehydrated, and embedded in Embed 812 resin.
Ultrathin sections were stained in uranyl acetate and lead citrate and examined under a
JEOL JEM-1230 transmission electron microscope (JEOL, Akishima, Tokyo, Japan).
4.9. Assessment of Retinal/RPE Adhesion
To determine the extent of retinal adhesion to the RPE, eyes were collected from B6 and
tvrm77 mice at 1 month of age after CO2 asphyxiation and dissected as described [32]. Enucleated eyes were dissected in 20 mM HEPES-buffered Hank’s saline solution containing
calcium and magnesium (Mediatech, Manassas, VA, USA) at room temperature. A circumferential cut was made below the limbus, and the iris, cornea, and lens were removed.
The posterior eyecup was placed in a clean petri dish and flattened with one radial cut
toward the optic nerve. The retina was peeled from the RPE by gentle separation with
forceps, snap frozen, and stored at −80 ◦ C. To quantify adhesion, samples were sonicated
in lysis buffer (1× NuPAGE LDS Sample Buffer NP0007 and 1× NuPAGE Sample Reducing
Agent NP0004, Thermo Fisher Scientific, Waltham, MA, USA) and centrifuged at 1000 rpm
for 1 min to pellet any remaining whole tissue. The supernatant was heated at 100 ◦ C
for 10 min prior to loading. A dilution series of the B6 samples was used to standardize
the Western signal. Samples were run on a 10% Mini-Protean TGX Precast acrylamide
gel (Bio-Rad, Hercules, CA, USA; 4561035) and transferred to nitrocellulose membranes.
Membranes were probed with antibodies against ezrin (1:1000; Cell Signaling, 3145), chemiluminescence was detected using Clarity Western ECL Substrate (Bio-Rad, Hercules, CA,
USA; 1705060), and total protein was assessed by Ponceau S staining. Membranes were
imaged using an Azure c600 bioimaging system. The raw integrated densities of the ezrin
bands and of Ponceau S bands on the same blots were determined using Fiji following
subtraction of background intensity determined in empty lanes. Density values for the
standard series were plotted against load volume and fit to a hyperbolic or sigmoidal curve
in Prism, which was used to calculate the equivalent load volumes for all samples. Relative
ezrin was determined by dividing the equivalent load volumes of the ezrin band by those
of the corresponding total protein. Relative ezrin values were normalized by dividing by
the mean value for all B6 samples.
4.10. Fluorescence Microscopy of Retinal Flatmounts
Retinal flatmounts were prepared as described. Briefly, eyes were removed and immediately fixed on ice in PBS containing 4% w/v paraformaldehyde. Eyecups were prepared
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within 30 min and cut radially before separating the retina from the RPE/choroid/sclera.
Following overnight blocking at 4 ◦ C with 5% normal donkey serum (Jackson ImmunoResearch, West Grove, PA, USA; 017-000-121), retinas were washed twice with PBS and stained
with isolectin B4 AlexaFluor 647 conjugate (Thermo Fisher Scientific, Waltham, MA, USA;
I32450) diluted 1:100 in PBS, 1 mM CaCl2 , 0.5% Triton X-100. After staining for four days at
4 ◦ C, samples were rinsed twice with PBS and mounted in VectaShield (Vector Laboratories,
Burlingame, CA, USA). Tiled z-stacks (2.0 µm step size) capturing the full thickness of the
entire retina were acquired at 20× by using a translational stage and ApoTome accessory
of an Axio Observer Z1 microscope (Carl Zeiss, Oberkochen, Germany). Tiles were stitched
with ZEN 2.6 software and exported in TIFF format to Fiji/ImageJ for maximum intensity projection and to adjust brightness and contrast. To display neovascular structures,
full-thickness regions of interest, in which vascular deviations appeared below the deep
vascular plexus, were selected from the image volume. A maximum intensity z-projection
was generated from an orthogonal reslice of these regions of interest.
4.11. Electroretinography
ERG components generated by the outer retina and RPE were evaluated in two
recording sessions using published protocols [97].
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